Skip to content
← Back to this collection

PUBLICATIONS · 21968943

A phase II study of O6-benzylguanine and temozolomide in pediatric patients with recurrent or progressive high-grade gliomas and brainstem gliomas: a Pediatric Brain Tumor Consortium study.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
J Neurooncol
Publication date
2012 Feb
First author
Warren KE

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Warren KE
      type
      Author
    2. name
      Gururangan S
      type
      Author
    3. name
      Geyer JR
      type
      Author
    4. name
      McLendon RE
      type
      Author
    5. name
      Poussaint TY
      type
      Author
    6. name
      Wallace D
      type
      Author
    7. name
      Balis FM
      type
      Author
    8. name
      Berg SL
      type
      Author
    9. name
      Packer RJ
      type
      Author
    10. name
      Goldman S
      type
      Author
    11. name
      Minturn JE
      type
      Author
    12. name
      Pollack IF
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Warren KE
      type
      Author
    2. name
      Gururangan S
      type
      Author
    3. name
      Geyer JR
      type
      Author
    4. name
      McLendon RE
      type
      Author
    5. name
      Poussaint TY
      type
      Author
    6. name
      Wallace D
      type
      Author
    7. name
      Balis FM
      type
      Author
    8. name
      Berg SL
      type
      Author
    9. name
      Packer RJ
      type
      Author
    10. name
      Goldman S
      type
      Author
    11. name
      Minturn JE
      type
      Author
    12. name
      Pollack IF
      type
      Author
    bibliography ids
    1. nci-bib-90f2f5edc37b1163c192608a
    book metadata
    content sha256
    2815d36df55166df600e07cb31e28221df66d602f3a1aa2ba0e853b1c39a308d
    document type
    citation
    dois
    1. 10.1007/s11060-011-0709-z
    electronic publication date
    display
    2011 Oct 4
    precision
    day
    year
    2011
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:21968943
    immutable id
    pubmed:21968943@2815d36df55166df600e07cb31e28221df66d602f3a1aa2ba0e853b1c39a308d
    journal
    abbreviation
    J Neurooncol
    issn electronic
    1573-7373
    issn print
    0167-594X
    issue
    3
    name
    Journal of neuro-oncology
    nlm unique id
    8309335
    pages
    643-9
    volume
    106
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      21968943
      provenance
      batch id
      2529ef2eca926738ab13
      provider
      NCBI PubMed ESummary
      record sha256
      61392523c15f88f064b036c205a14a66f2c8ee7533114a3c8f1578b0a129ab30
      response sha256
      9204e3dd8d67df5a6773613a8059d8d42d9842ee24eecc9b0f39a62f636c99b6
      retrieved at
      2026-09-09T23:46:42.856296+00:00
      publication date
      display
      2012 Feb
      precision
      month
      year
      2012
      publication types
      1. Clinical Trial, Phase II
      2. Journal Article
      3. Research Support, N.I.H., Extramural
      4. Research Support, N.I.H., Intramural
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/21968943/
      title
      A phase II study of O6-benzylguanine and temozolomide in pediatric patients with recurrent or progressive high-grade gliomas and brainstem gliomas: a Pediatric Brain Tumor Consortium study.

      Preserved source evidence · Not medical advice